Strategic B2B Sourcing for Russian Pharmaceutical Importers & Addiction Recovery Clinics
Sky High Medex is a specialized pharmaceutical exporter providing Naltivia 50 Tablets to licensed medical wholesalers, private rehabilitation centers, and institutional procurement groups across Russia. Manufactured by Ethinext Pharma, Naltivia contains Naltrexone Hydrochloride (50mg), a high-purity opioid antagonist utilized in professional clinical settings as a foundational treatment for alcohol and opioid dependence.
B2B Order Details:
Minimum Order Quantity (MOQ): 500 Tablets (Strictly Wholesale).
Active Ingredient: Naltrexone Hydrochloride 50mg.
Manufacturer: Ethinext Pharma.
Therapeutic Class: Opioid Antagonist / Anti-addiction Agent.
Format: Film-Coated Tablet.
The Sky High Medex Advantage for the Russian Market:
Direct Export Economies: Optimize procurement margins for healthcare networks in Moscow, Saint Petersburg, and Novosibirsk by sourcing directly from our Indian wholesale center, offering significant cost-efficiency for long-term recovery supplies.
Ethinext Pharma Quality: Access a reliable formulation produced under strict quality controls, ensuring the chemical stability and potency required for sensitive therapeutic protocols in clinical addiction medicine.
Verified Export Authority: We operate with a valid Import-Export Code (IEC) and GST registration, providing a 100% transparent and professional trade trail for Russian-based corporate and medical entities.
Full Documentation Suite: Every shipment is accompanied by a Certificate of Analysis (COA), detailed commercial invoices, and packing lists to support institutional auditing and cross-border trade compliance.
Logistics & Russia Customs Support:
While domestic import licenses and adherence to the Ministry of Health (Minzdrav) or Roszdravnadzor guidelines remain the responsibility of the importer, Sky High Medex ensures all Indian export formalities are handled with professional precision. We offer reliable air-freight shipping to major Russian hubs, including Moscow Sheremetyevo (SVO) and Domodedovo (DME).
Technical Insight & Pharmacological Action:
Naltivia (Naltrexone 50mg) is recognized for its targeted receptor-blocking capabilities. In a clinical and research context, it is noted for:
Mechanism of Action: Naltrexone is a pure opioid antagonist that competitively binds to $\mu$, $\delta$, and $\kappa$ opioid receptors. This blockade prevents the euphoric effects of exogenous opioids and reduces the physiological "reward" associated with alcohol consumption.
Alcohol Dependence Management: Indicated as part of a comprehensive treatment program to help patients maintain abstinence and reduce the craving for alcohol.
Opioid Recovery Support: Utilized to prevent relapse in patients who have successfully completed opioid detoxification. It is non-addictive and does not cause physical dependence.
Pharmacokinetic Profile: Following oral administration, Naltrexone is rapidly absorbed, reaching peak plasma concentrations within approximately one hour. It is primarily metabolized in the liver to the active metabolite 6-$\beta$-naltrexol.
👉
📦 Request a Wholesale Quote for Russia
Direct B2B support for Russia-based pharmaceutical buyers and healthcare distributors.
WhatsApp: +91 9270847472
Email: skyhighmedex@gmail.com
Location: Nagpur Export Hub / International Service Desk
